Clinical Efficacy of Fuyang Huaji Formula and Tislelizumab in the Treatment of Non-small Cell Lung Cancer

Clinical Efficacy of Fuyang Huaji Formula and Tislelizumab in the Treatment of Non-small Cell Lung Cancer

JIANG Xiaoxia, SHU Xingwei, YE Yong

PDF(1023 KB)

PDF(1023 KB)

Chinese And Foreign Medical Research ›› 2025, Vol. 23 ›› Issue (13) : 1-5. DOI: 10.14033/j.cnki.cfmr.2025.13.001

Article

Clinical Efficacy of Fuyang Huaji Formula and Tislelizumab in the Treatment of Non-small Cell Lung Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 23(13): 1-5 https://doi.org/10.14033/j.cnki.cfmr.2025.13.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1023 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉